R. Rudel et al., IMPLICATIONS OF ARSENIC GENOTOXICITY FOR DOSE-RESPONSE OF CARCINOGENIC EFFECTS, Regulatory toxicology and pharmacology, 23(2), 1996, pp. 87-105
Epidemiological data relating arsenic ingestion and skin and internal
cancers strongly suggest a sublinear or threshold relationship. Physio
logical saturation of methylation-based arsenic detoxification has bee
n proposed as one explanation for a sublinear response. We have evalua
ted the molecular bases for sublinearity in Light of new data and hypo
theses regarding arsenic genotoxicity and chemical carcinogenesis. A r
eview of the dose-response relationships observed in arsenic genotoxic
ity assays is presented. With the exception of sister chromatid exchan
ges, sublinear dose-response relationships for arsenic-induced chromos
omal aberrations were observed repeatedly in different mammalian and h
uman cell systems. Arsenic also enhanced the clastogenicity and mutage
nicity of other DNA damaging agents with a sublinear dose response. Co
nsistent with the dose response of arsenic-induced genetic alterations
, arsenic also inhibited DNA ligases I and II, enzymes which play a ro
le in DNA repair, with a sublinear dose response. In some cases, prote
ctive effects of relatively low exposures to arsenic have been observe
d, again consistent with sublinearity. We discuss recent theories on t
he mechanism of arsenic carcinogenicity and the potential implications
for dose-response modeling and risk assessment. Overall, based on ava
ilable arsenic genotoxicity data, we conclude that it is likely that a
rsenic indirectly induces genetic damage with a sublinear dose respons
e in humans, thus providing a biological basis for a sublinear dose-re
sponse relationship for human cancer. Furthermore, these results sugge
st that linear dose-response modeling from populations experiencing hi
gh arsenic exposures is likely to overpredict cancer risks at relative
ly low arsenic levels. (C) 1996 Academic Press, Inc.